2-(4-chlorophenyl)-N-methoxy-N-methylacetamide, 95.0%, 2g

Zernike phase contrast set PLPHi 10/20/40/100 IOS bright field and dark field position

[2,2'-BIPYRIMIDINE]-5-CARBOXYLIC ACID, 95.0%, 250mg

2-Oxa-5-azaspiro[3.4]octane hydrochloride, 98%, 25mg

3,6-Dibromobenzene-1,2-diamine, 95.0%, 1g

Fmoc-Lys(Z)-OH, 95%, 1g

2-oxo-1,2-dihydroquinoline-4-carboxylic acid, 95.0%, 25g

(2S,5S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-5-methylpyrrolidine-2-carboxylic acid, 97%, 100mg

(S)-Glycidoxy-t-butyldimethylsilane, >95.0%(GC), 25g

Methyl 4-(trifluoromethyl)picolinate, 95.0%, 1g

1-Boc-4-Amino-3-fluoropiperidine, 95.0%, 1g

(R)-2-Phenyl-propionic acid, 99.00%, 10g

2-(Hydroxymethyl)thiophen-3-ylboronic acid, 95+%, 1g